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Reinventing chemical manufacturing: 
toward a compact and mobile factory?




Expertise in organic chemistry & flow chemistry 
3 main research areas:
• APIs (small molecules & peptides)
• Biomass and platform molecules








CiTOS - Where organic chemistry meets technology
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Chemical manufacturing





• Purity is paramount
• Variable scale (fine chemicals)
• Macroscopic (batch)
• (usually) Single step
• “Basic” chemistry
• Purity is less critical
• Very large scale (bulk, commodity)
• Macroscopic reactors (flow)






Complex multistep processes on large scale












lab: hours to days




Multistep processes on large scale






































































Multistep processes on large scale
Drug shortages 
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• 2010 diphenhydramine massive 
recall
• lidocaine and diazepam flagged on 






Multistep processes on large scale
Bad reputation – NIMBY syndrom
• 2000-2014: 85 (US) / 111 (EU) serious chemical incidents in organic 
chemistry-related industry





A new paradigm for chemical manufacturing
Cleaner, flexible, more efficient continuous manufacturing
“Right now, manufacturing experts from the 1950s would easily recognize the
pharmaceutical manufacturing processes of today. It is predicted that
manufacturing will change in the next 25 years as current manufacturing
practices are abandoned in favor of cleaner, flexible, more efficient continuous
manufacturing.”
Dr. Janet Woodcock (FDA), AAPS Annual meeting, October 2011
“Drug manufacturers typically produce drugs in batches in large factories. But a
new trend is developing in the pharmaceutical industry to reduce infrastructure
costs by using small continuous-flow systems to make drug doses on demand.”
Stu Borman, Chemical and Engineering News, February 2017
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Mobile, compact, reconfigurable, versatile, sustainable
http://corporate.evonik.com
Emerging manufacturing technology
A new paradigm for chemical manufacturing
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Ang Chem Int Ed 2013, 52, 12359Org Proc Res Dev 2014, 18, 402
•Compact (15 m²)
•Fully integrated (up /downstream+formulation)
•Modulable (output: 20 g h-1 and 100 g h-1)
Emerging manufacturing technology
A new paradigm for chemical manufacturing
Technology breakthroughs
12
On-Demand Drug Production Is on the 
Horizon
The Drug-Making Process Is Slow and 
Wasteful — This Machine Could Fix That
A new paradigm for chemical manufacturing
Technology breakthroughs
Emerging manufacturing technology




GCI/2007: continuous manufacturing is a research top priority
Org Proc Res Dev 2011, 15, 900; Green Chem 2012, 14, 38
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Flow chemistry






























































“with strong expertise in flow chemistry,…
experience/expertise in photo-redox chemistry or
photo-redox reaction in flow is desirable”
“Working across skills sets such as flow 
chemistry …”
“A Ph.D. in chemistry with experience in flow 
chemistry is required, …”
“Applies applications for new technologies to 
project objectives, e.g. flow chemistry”
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What is flow chemistry?
Flow chemistry is a term widely used to describe the performance of a 
reaction in a continuous manner, in a micro/mesofluidic reactor.
KEY
FEATURES
Batch reactors Continuous-Flow 
micro/mesoreactors
3D internal structure >> 104 µm
mL < internal volume < kL
Finite volume of chemicals
3D internal structures < 10³ µm 
µL < internal volume < mL





• Used in labs, R&D and production
• Continuous reactors with well defined micro or meso structures (< 1000 µm)
and internal volumes (µL to mL)





Channel Ø: 100 µm
Vint: 100+ µL
Channel Ø: 100-800 µm
Vint: up to mL
micro
meso
What is flow chemistry?
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Continuous micro/mesofluidic reactors
Anatomy of a continuous-flow reactor
What is flow chemistry?
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What is flow chemistry?
End-to-end continuous manufacturing
The telescoping of complex multistep continuous-flow sequences 




Inherent differences between macroscopic batch and microreactors
The behavior of liquids at a microscopic scale is quite distinct from that for ﬂuids at 
a macroscopic level
• At a macroscopic scale, pressures well above or below atmospheric pressure and 
gravity dominate ﬂuid dynamics
• Surface tension, energy dissipation, and fluidic resistance start to dominate the 













• Mixing is poor (tmix >> treac)
• Heat transfer is slow
• Difficult control of reaction time
• Low surface/volume ratio
• Intensification = hazard
• Chemical hazard!
• Less for transient species
• Scale-up is time consuming
Flow (micro/meso)reactors
• 3D internal structures < 1000 µm
• Scale independent
• Space-resolved
• Mixing is fast (tmix << treac)
• Heat transfer is fast
• Control of reaction time
• High surface/volume ratio
• Intensification = safe
• Inherently safer
• Suitable for transient species
• Fast scaling-out or numbering-up
Flow chemistry: what benefits?
Flow chemistry redefines chemical processing
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Flow chemistry: what benefits?
Flow chemistry enables faster, more selective and inherently safer 
chemical transformations. 






Micromixing (active & passive)
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Flow chemistry: what benefits?
Faster mixing & better heat exchange
Reactor type Surface/volume (cm²/cm³) 
100 mL reaction bulb 1 
1 m³ reactor 0.06 
µchannel 100 µm 200 
 
Flow chemistry enables faster, more selective and inherently safer 
chemical transformations. 
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Fine tuning of reaction time
Flow chemistry: what benefits?
Corning proprietary
Flow chemistry enables faster, more selective and inherently safer 
chemical transformations. 
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Inherent safety – finite vs infinite volumes
Flow chemistry: what benefits?
Large  amount of 
processed material / unit of time
Flow chemistry enables faster, more selective and inherently safer 
chemical transformations. 
Small amount 










Unconventional conditions are easily accessible
Flow chemistry: what benefits?
Flow chemistry enables the handling of unstable/hazardous species 













Seamless transition from lab-scale to production-scale
Flow chemistry: what benefits?





Pharmacy on demand 









• Single operator & user friendly
• Easy maintenance, adaptable, versatile,     
reconfigurable
• High yield, high purity of all APIs




















Science, 2016, 352, 61









Case studies – part I 
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Case studies – part II
Continuous-flow process toward methylphenidate hydrochloride
Reaction telescoping with unstable/explosive intermediates
Work with R. Gérardy
React. Chem. Eng. 2017, 2, 149.
Patent application No. EP16189458.9























• most widely prescribed stimulant API 
for ADHD and narcolepsy
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Case studies – part II 
Continuous-flow process toward methylphenidate hydrochloride



















- multistep sequential batch
- inventories of hazardous chemicals
- reaction times up to 5.5 h (inter 
  and intra)
- hazardous scale-up
This work:
- telescoped multistep continuous-flow
- no inventories of hazardous chemicals
- reaction times up to 20 min (inter) and 
  25 min (intra)




5b3b (X = N-NHTs)













React. Chem. Eng. 2017, 2, 149.
Patent application No. EP16189458.9
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Case studies – part II 
Reaction telescoping with unstable/explosive intermediates
Seamless scale-out: Corning® Advanced-FlowTM LF to G1TM reactors
• PFA µreactor: 21.7 g day-1 (1400 doses)
• LowFlow: 86.9 g day-1 (5,800 doses)
• G1: 4.25 kg day-1 (280,000 doses)
~ 2 min residence time
Corning proprietaryCorning proprietary




• Significant reduction of spatiotemporal requirements
• Expands the toolkit for chemical processing
• Compatible with unstable materials and unconventional
conditions
• Intensification/seamless transition toward larger scales
• Safer, greener, faster processes
Inspiring reading: “Flow chemistry—Microreaction technology




• Chemical challenges (new paradigm)
• Technology challenges (mechanical & chemical resistance)
• Increasing process/molecular complexity
Tim Jamison,  MIT
http://www.in-pharmatechnologist.com/Processing/Lack-of-talent-will-hamper-continuous-manufacturing-uptake-MIT-Prof
“A lack of scientific talent will hold pharma back from adopting 
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